At the time of the deal , Sen. Max Baucus , D-Mont . , chair of the Senate Finance Committee , announced that pharmaceutical companies had agreed to a deal as part of an overall health care reform package , where the companies will provide , as Baucus put it , " affordable prices on prescription drugs when Medicare benefits don 't cover the cost of prescriptions , " as well as kicking in some money for health care reform efforts .